Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets [Phase 1]

View source ↗

Summary

A Phase 1 trial sponsored by Sandoz evaluated the relative bioavailability of Desipramine Hydrochloride 50 mg tablets in adults with depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desipramine hydrochloride 50 mg tablets (desipramine)

Snippet

Sponsor: Sandoz | Conditions: Depression | Phase 1 | Status: COMPLETED